The eye maintains normal pressure and function through a fluid called aqueous humor, which is continuously produced and drained through a structure known as the iridocorneal angle. In dogs affected by POAG-4, genetic mutations disrupt the normal architecture or function of this drainage system. As a result, fluid does not drain efficiently, leading to a gradual buildup of pressure inside the eye. Over time, this increased pressure damages the optic nerve, which is responsible for transmitting visual information from the eye to the brain.
Clinical signs of POAG-4 often develop slowly and may not be noticeable in the early stages. Initial symptoms can include mild eye discomfort, occasional redness, excessive tearing, or subtle behavioral changes such as reluctance to navigate unfamiliar areas. As the disease progresses, more obvious signs may appear, including corneal cloudiness, pupil dilation, reduced vision, and increased sensitivity to light. In advanced stages, affected dogs may experience enlargement of the eye (buphthalmos), severe vision impairment, and eventual blindness due to irreversible optic nerve damage.
The POAG-4 DNA Health Test is designed to detect the specific genetic mutation associated with this form of Primary Open Angle Glaucoma. Testing is simple, safe, and non-invasive, typically performed using a cheek swab or blood sample. The collected sample is analyzed in a specialized laboratory to determine whether the dog carries zero, one, or two copies of the mutation. Since DNA remains unchanged throughout life, testing can be performed at any age, including before any clinical signs develop.
Results are generally reported in three categories:
- Clear (Normal): The dog does not carry the POAG-4 mutation and is not expected to develop this genetic form of glaucoma or pass it to offspring.
- Carrier: The dog carries one copy of the mutation and may not show clinical signs, but can pass the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and has a significantly increased likelihood of developing Primary Open Angle Glaucoma (POAG-4).
Genetic testing for POAG-4 provides valuable information for breeders, veterinarians, and dog owners. Breeders can use test results to make informed decisions that help reduce the prevalence of inherited glaucoma while maintaining healthy genetic diversity within the breed population. Avoiding carrier-to-carrier breeding significantly reduces the risk of producing affected puppies.
For dog owners, knowing a dog’s genetic status allows for proactive eye health monitoring and early veterinary intervention. Dogs identified as at risk should undergo regular ophthalmic examinations to monitor intraocular pressure and detect early changes in the eye. While there is currently no cure for optic nerve damage caused by glaucoma, early treatment using pressure-lowering medications, laser therapy, or surgical options may help slow disease progression and preserve vision for as long as possible.
The Primary Open Angle Glaucoma (POAG-4) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine ocular health, and helps reduce the impact of this inherited cause of blindness in future generations.
